SCHEMBL18555000

SCHEMBL18555000

CC(=CC(=O)OF)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DEGS1 O15121 1/20 0.46
NR4A1 P22736 1/20 0.43
NR4A2 P43354 1/20 0.43
NR4A3 Q92570 1/20 0.43
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 2/20 0.41
NFE2L2 Q16236 1/20 0.39
LTB4R Q15722 4/20 0.39
LTB4R2 Q9NPC1 4/20 0.39
ELANE P08246 1/20 0.39
F2 P00734 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9660257 0.82 DEGS1 (0.47) DEGS1NR4A1NR4A2NR4A3CES2
SCHEMBL7995954 0.82 TSHR (0.52) DEGS1NR4A1NR4A2NR4A3CES2
SCHEMBL7995955 0.82 TSHR (0.52) DEGS1NR4A1NR4A2NR4A3CES2
SCHEMBL10830070 0.82 TSHR (0.52) DEGS1NR4A1NR4A2NR4A3CES2
SCHEMBL9450419 0.81 DEGS1 (0.46) DEGS1NR4A1NR4A2NR4A3CES2
SCHEMBL28390998 0.79 DEGS1 (0.42) DEGS1NR4A1NR4A2NR4A3CES2
SCHEMBL2205707 0.78 MAPT (0.51) DEGS1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL2205704 0.78 MAPT (0.51) DEGS1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL5078615 0.78 MAPT (0.51) DEGS1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL28397010 0.78 ELANE (0.49) DEGS1SMN1; SMN2MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3340981-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2018-07-04 EP disclosed
WO-2017035353-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 WO disclosed